+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

MCL1 Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

MCL1 Protein Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Minimal Residual Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Minimal Residual Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Disease Analysis: Osteoporosis - Product Thumbnail Image

Disease Analysis: Osteoporosis

  • Report
  • March 2021
  • 48 Pages
  • Global
From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
From
Menopausal Hot Flashes Market 2021-2025 - Product Thumbnail Image

Menopausal Hot Flashes Market 2021-2025

  • Report
  • October 2021
  • 120 Pages
  • Global
From
From
Loading Indicator